Avoiding these locations lowers personal risk of infection. Clinics, hospitals and facilities are determining what care will continue and what can be delayed or rescheduled. Some routine tests or procedures may not be necessary if an individual has no symptoms or risk factors, while others should not delay. Individuals should speak with their health care provider. Health care professionals are also offering care virtually.
Physical distancing, along with handwashing, are the most effective ways to reduce the spread of COVID-19. Avoid crowds, unnecessary travel, and social gatherings. Individuals should only go out for groceries, to the pharmacy, or other essential trips. Decreasing the spread of COVID-19 can help alleviate the pressure on the health care system.
Available data from studies on patients affected by other viral infections are conflicting and in some cases subject to multiple biases, although many highlight that treatment could produce a variety of adverse effects on patients.
Despite these data, some scientific societies have defined situations in which corticosteroid treatment can be used to palliate the uncontrolled inflammatory response caused by the virus, although there is no unanimity in their proposals.
The absence of studies on ...
Cochrane Portugal - Institute for Evidenced Based Health
This document provides guidance to WHO Member States on the implementation of surveillance for COVID-19 disease, through the following infection definitions:
Suspicious case: A) a patient with acute respiratory illness (fever and at least cough or difficulty breathing) and no other cause that fully explains the clinical presentation + a history of travel or residence in a country, area, or territory that reported a local transmission of SARS-CoV-2 during the 14 days prior to the onset of ...
Cochrane Portugal - Institute for Evidenced Based Health
In a clinical trial with a sample of 199 patients hospitalized for severe SARS-CoV-2, showed no statistically significant difference in the main results. The group treated with LR had a numerically lower mortality at 28 days (19.2% vs. 25%), the average delay in intensive care was less (6 vs. 11 days) and the percentage of patients with clinical improvement at 14 days was greater (45.5 vs. 30%). All these results allow us to believe in the possibility that, if the study had continued with the ...